Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-038809
Filing Date
2013-08-01
Accepted
2013-08-01 19:10:35
Documents
1
Period of Report
2013-07-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 17318
  Complete submission text file 0001209191-13-038809.txt   19007
Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Issuer) CIK: 0001383701 (see all company filings)

EIN.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONATUS PHARMACEUTICALS INC. 4365 EXECUTIVE DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address C/O CONATUS PHARMACEUTICALS INC. 4365 EXECUTIVE DRIVE, SUITE 200 SAN DIEGO CA 92121 (858) 457-7222
COOPERATIVE GILDE HEALTHCARE II U.A. (Reporting) CIK: 0001581748 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36003 | Film No.: 131004132